Preferred Label : factor XIIIa;
MeSH definition : Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation
of the fibrin polymer (clot) culminating the blood coagulation cascade.;
MeSH synonym : factor xiii, activated; fibrinoligase; blood coagulation factor xiii, activated; activated factor xiii; Factor Thirteen A; Factor 13A;
CISMeF synonym : xiiia, factor;
MeSH hyponym : plasma transglutaminase; Transglutaminase, Plasma;
Registry Number MeSH : EC 2.3.2.13;
MeSH annotation : distinguish X ref PLASMA TRANSGLUTAMINASE from TRANSGLUTAMINASES; distinguish entry term PLASMA TRANSGLUTAMINASE from TRANSGLUTAMINASES;
Is substance : O;
UNII : EC 2.3.2.13;
Origin ID : D026122;
UMLS CUI : C0015533;
Allowable qualifiers
Indexing information
- AM2-97 [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation
of the fibrin polymer (clot) culminating the blood coagulation cascade.
https://www.has-sante.fr/jcms/p_3224931/fr/novothirteen
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
Catridecacog (substance)
catridecacog
factor XIIIa
factor XIIIa
factor xiii deficiency
injections, intravenous
orphan drug production
hemorrhage
factor xiii deficiency
recombinant proteins
---
https://www.ema.europa.eu/medicines/human/EPAR/NovoThirteen
2012
United Kingdom
English
French
catridecacog
drug approval
treatment outcome
recombinant proteins
recombinant proteins
factor XIIIa
factor XIIIa
factor xiii deficiency
factor XIIIa
factor xiii deficiency
hemorrhage
child
adolescent
adult
orphan drug production
injections, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
Congenital factor XIII deficiency
---